XRAY

DENTSPLY SIRONA Inc. [XRAY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

XRAY Stock Summary

Top 10 Correlated Stocks

XRAY


In the News

11:11 28 Mar 2024 XRAY

Here's Why Dentsply International (XRAY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

10:41 28 Mar 2024 XRAY

Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

10:36 28 Mar 2024 XRAY

Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Dentsply (XRAY) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

09:51 28 Mar 2024 XRAY

DENTSPLY SIRONA (XRAY) Q4 Earnings Beat Estimates, Sales Up Y/Y

DENTSPLY SIRONA's (XRAY) Q4 revenues improve year over year. Challenging macro headwinds linger.

08:11 28 Mar 2024 XRAY

Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.46 per share a year ago.

12:41 28 Mar 2024 XRAY

What's in Store for DENTSPLY SIRONA (XRAY) in Q4 Earnings?

DENTSPLY SIRONA's (XRAY) fourth-quarter 2023 results are likely to reflect a recovery in demand for consumable products, partially offset by lower sales in China due to volume-based procurement policy.

01:11 28 Mar 2024 XRAY

Will Dentsply (XRAY) Beat Estimates Again in Its Next Earnings Report?

Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

04:15 28 Mar 2024 XRAY

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th

CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

08:30 28 Mar 2024 XRAY

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results

CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company's previously provided outlook range of $3.90 billion to $3.94 billion. For the full year and fourth quarter 2023, the Company expects to report year-over-year net sales growth in the Essential Dental Solutions, Wellspect Healthcare, and Orthodontic and Implant Solutions segments, partially offset by declines in the Connected Technology Solutions segment. The Company is reaffirming its full year 2023 adjusted EPS outlook range of $1.80 to $1.85 and its expectations for double-digit adjusted EPS growth in 2024. The Company does not provide forward-looking or preliminary estimates of adjusted EPS on a GAAP basis as certain information needed to prepare adjustments is not yet available and cannot be reasonably estimated. A description of the adjustments typically made to compute adjusted EPS can be found in Exhibit 99.1 to the Company's Current Report on Form 8-K filed on November 2, 2023.

08:00 28 Mar 2024 XRAY

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).

XRAY Financial details

Company Rating
Strong Buy
Market Cap
6.79B
Income
-136M
Revenue
2.97B
Book val./share
15.68
Cash/share
1.59
Dividend
0.56
Dividend %
1.71%
Employees
15K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-50.71
Forward P/E
21.22
PEG
5.93
P/S
2.29
P/B
2.09
P/C
20.95
P/FCF
29.87
Quick Ratio
0.76
Current Ratio
1.38
Debt / Equity
0.66
LT Debt / Equity
0.55
-
-
EPS (TTM)
-0.64
EPS next Y
1.57
EPS next Q
0.59
EPS this Y
-85.94%
EPS next Y
-344.53%
EPS next 5Y
-421.36%
EPS last 5Y
NAN%
Revenue last 5Y
-0.32%
Revenue Q/Q
-98.31%
EPS Q/Q
-125.4%
-
-
-
-
SMA20
-1.37%
SMA50
-8.69%
SMA100
6.93%
Inst Own
73.94%
Inst Trans
0.78%
ROA
-2%
ROE
-4%
ROC
-0.01%
Gross Margin
37%
Oper. Margin
-3%
Profit Margin
-5%
Payout
-85%
Shs Outstand
207.36M
Shs Float
205.37M
-
-
-
-
Target Price
47.88
52W Range
26.27-43.24
52W High
-22.53%
52W Low
+28.12%
RSI
49.71
Rel Volume
0.79
Avg Volume
2.83M
Volume
2.23M
Perf Week
1%
Perf Month
2.65%
Perf Quarter
0.03%
Perf Half Y
-2.52%
-
-
-
-
Beta
0.998
-
-
Volatility
0.32%, 0.41%
Prev Close
2.49%
Price
33.31
Change
1.22%

XRAY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
18.0615.2519.4618.2118.7
Net income per share
1.18-0.381.88-4.41-0.62
Operating cash flow per share
2.842.93.012.41.78
Free cash flow per share
2.292.52.361.711.08
Cash per share
1.992.151.651.811.58
Book value per share
22.8422.6723.0917.715.53
Tangible book value per share
-2.14-6.93-5.73-3.62-4
Share holders equity per share
22.8422.6723.0917.715.53
Interest debt per share
7.111.210.519.9910.56
Market cap
12.63B11.48B12.18B6.86B7.55B
Enterprise value
13.78B13.45B14.09B8.59B9.51B
P/E ratio
48.02-138.2829.65-7.22-57.16
Price to sales ratio
3.133.432.871.751.9
POCF ratio
19.9518.0718.5513.2720.01
PFCF ratio
24.7620.9423.6618.6433.09
P/B Ratio
2.482.312.421.82.29
PTB ratio
2.482.312.421.82.29
EV to sales
3.424.023.312.192.4
Enterprise value over EBITDA
16.317.0214.0613.5414.91
EV to operating cash flow
21.7721.1821.4416.6125.23
EV to free cash flow
27.0224.5427.3523.3341.71
Earnings yield
0.02-0.010.03-0.14-0.02
Free cash flow yield
0.040.050.040.050.03
Debt to equity
0.310.480.440.550.66
Debt to assets
0.180.260.240.270.29
Net debt to EBITDA
1.362.491.92.733.08
Current ratio
2.011.361.551.621.38
Interest coverage
17.779.511.315.14.61
Income quality
2.41-7.651.56-0.54-2.86
Dividend Yield
0.010.010.010.020.02
Payout ratio
0.31-1.060.22-0.11-0.88
Sales general and administrative to revenue
000.360.410.41
Research and developement to revenue
0.030.030.040.040.05
Intangibles to total assets
0.650.690.680.60.56
Capex to operating cash flow
-0.19-0.14-0.22-0.29-0.4
Capex to revenue
-0.03-0.03-0.03-0.04-0.04
Capex to depreciation
-0.38-0.26-0.41-0.45-0.43
Stock based compensation to revenue
0.020.010.010.020.01
Graham number
24.6113.931.2741.914.75
ROIC
0.060.080.060.050.04
Return on tangible assets
0.09-0.030.14-0.31-0.04
Graham Net
-9.84-14.43-13.75-12.32-13.5
Working capital
1B474M651M723M548M
Tangible asset value
-477.9M-1.52B-1.25B-779M-849M
Net current asset value
-1.51B-2.58B-2.34B-1.94B-2.1B
Invested capital
0.310.480.440.550.66
Average receivables
741.95M727.5M710M689.5M694M
Average payables
295.9M306.45M286.5M273.5M292M
Average inventory
580.3M513.85M485M565.5M625.5M
Days sales outstanding
70.8473.564.1458.8269.59
Days payables outstanding
60.2966.0751.7656.7359.34
Days of inventory on hand
109.98100.9497.33127.5121.41
Receivables turnover
5.154.975.696.215.24
Payables turnover
6.055.527.056.436.15
Inventory turnover
3.323.623.752.863.01
ROE
0.05-0.020.08-0.25-0.04
Capex per share
-0.55-0.4-0.65-0.69-0.7

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.574.634.854.470.08
Net income per share
-0.07-0.110.41-1.260.32
Operating cash flow per share
0.66-0.10.490.630.76
Free cash flow per share
0.51-0.280.340.460.57
Cash per share
1.811.511.391.461.59
Book value per share
17.7217.2517.4715.9215.68
Tangible book value per share
-3.62-4.38-3.82-3.37-4.04
Share holders equity per share
17.7217.2517.4715.9215.68
Interest debt per share
9.8210.9910.710.1110.45
Market cap
6.85B8.29B8.48B7.24B7.47B
Enterprise value
8.58B10.28B10.43B9.05B9.44B
P/E ratio
-114.15-90.1424.65-6.827.89
Price to sales ratio
6.978.488.257.64467.12
POCF ratio
48.23-394.8881.5453.9946.71
PFCF ratio
62.26-138.21119.4474.5962.28
P/B Ratio
1.82.282.292.152.27
PTB ratio
1.82.282.292.152.27
EV to sales
8.7310.5110.159.56589.93
Enterprise value over EBITDA
252.2674.4766.0253.54589.93
EV to operating cash flow
60.4-489.35100.367.5358.99
EV to free cash flow
77.97-171.27146.9293.2978.66
Earnings yield
000.01-0.040.01
Free cash flow yield
0.02-0.010.010.010.02
Debt to equity
0.550.630.610.630.66
Debt to assets
0.270.30.290.290.29
Net debt to EBITDA
50.8214.3812.3510.73122.81
Current ratio
1.621.411.511.571.38
Interest coverage
-2.372.843.81-13.110.8
Income quality
-9.470.911.22-0.52.39
Dividend Yield
00000
Payout ratio
-1.73-1.170.35-0.110.45
Sales general and administrative to revenue
00000
Research and developement to revenue
0.040.050.050.052.69
Intangibles to total assets
0.60.590.590.570.56
Capex to operating cash flow
-0.231.86-0.32-0.28-0.25
Capex to revenue
-0.03-0.04-0.03-0.04-2.5
Capex to depreciation
-0.41-0.46-0.38-0.42-0.47
Stock based compensation to revenue
0.010.020.0100.81
Graham number
5.276.512.6321.2110.61
ROIC
0.010.010.02-0.040
Return on tangible assets
0-0.010.03-0.090.02
Graham Net
-12.34-13.73-13.32-12.79-13.63
Working capital
723M569M649M695M548M
Tangible asset value
-779M-925M-809M-714M-849M
Net current asset value
-1.94B-2.09B-2.03B-1.92B-2.1B
Invested capital
0.550.630.610.630.66
Average receivables
638.5M642M661M659.5M702.5M
Average payables
275M273M266M263.5M283.5M
Average inventory
609.5M643M658M654M637.5M
Days sales outstanding
57.866058.6661.684.25K
Days payables outstanding
53.8852.3549.952.1756.02
Days of inventory on hand
121.09129.22123.7129.62114.61
Receivables turnover
1.561.51.531.460.02
Payables turnover
1.671.721.81.731.61
Inventory turnover
0.740.70.730.690.79
ROE
0-0.010.02-0.080.02
Capex per share
-0.15-0.18-0.16-0.17-0.19

XRAY Frequently Asked Questions

What is DENTSPLY SIRONA Inc. stock symbol ?

DENTSPLY SIRONA Inc. is a US stock , located in Charlotte of Nc and trading under the symbol XRAY

Is DENTSPLY SIRONA Inc. buy or a sell ?

9 stock analysts have 9 predictions with a medium analyst target price of $50.89. The lowest prediction is $35 and the highest is $75

What is XRAY stock prediction ?

What is DENTSPLY SIRONA Inc. stock quote today ?

DENTSPLY SIRONA Inc. stock price is $33.31 today.

Is DENTSPLY SIRONA Inc. stock public?

Yes, DENTSPLY SIRONA Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks